Recent Features

Preventing SSIs: An Evidence-Based Update

Preventing SSIs: An Evidence-Based Update | Feature

An updated guide provides evidence-based strategies for preventing surgical site infections (SSIs) and offers a framework to prioritize and implement strategies to reduce these infections. The SSI recommendations go beyond standard practices that are required by many organizations.

Hip Fracture Surgery: Costs & Benefits

Hip Fracture Surgery: Costs & Benefits | Opinion Article

According to current estimates, more than 300,000 patients—mostly people aged 65 and older—sustain a hip fracture each year in the United States, and the annual incidence is expected to exceed 500,000 by 2040. Hip fractures often result in nursing home stays, higher mortality, and lower quality of life.…

Cardiometabolic Risk, Type 2 Diabetes, & Heart Disease

Cardiometabolic Risk, Type 2 Diabetes, & Heart Disease | Feature

Cardiometabolic risk should be routinely assessed in patients with type 2 diabetes, and multiple prevention and management strategies may be required to achieve goals. Healthcare providers should have conversations with their patients about the connection between diabetes, heart disease, and stroke as well as the benefits of prevention.

Malpractice Reform’s Effect on ED Care

Malpractice Reform’s Effect on ED Care | Feature

Malpractice reform laws providing specific protections to emergency physicians do not appear to have any effect on their clinical practice, according to a study. The analysis found little support for the idea that such laws can yield savings by reducing defensive medicine.

Updated Guidelines for NSTE-ACS

Updated Guidelines for NSTE-ACS | Opinion Article

Recently, the American College of Cardiology and American Heart Association (ACC/AHA) updated their guideline on the management of patients with non-ST-elevation acute coronary syndrome (NSTE-ACS). “This guideline is the first full revision of previous recommendations since 2007,” says Ezra A. Amsterdam, MD, FACC, who co-chaired the ACC/AHA writing committee.…

An Update for Preventing MRSA

An Update for Preventing MRSA | Feature

Several expert groups have released new guidelines to help reduce the prevalence of MRSA and improve patient safety in hospitals. This guidance can serve as a roadmap for prioritizing and implementing MRSA prevention strategies.

Assessing Aspirin Use for CVD Prevention

Assessing Aspirin Use for CVD Prevention | Opinion Article

Aspirin is used as a primary strategy to help prevent a first occurrence of cardiovascular disease (CVD). It can also be used as secondary prevention for survivors of heart attacks and strokes to prevent additional cardiovascular events.

The American Heart Asso­ciation recommends daily low-dose aspirin for people at high risk of heart attacks and regular use of low-dose aspirin for heart attack survivors.…

Social Support After AMI

Social Support After AMI | Feature

Lower social support may increase the risk of poor health outcomes in young patients with acute myocardial infarction (AMI). Efforts to identify non-traditional cardiovascular risk factors like social support may offer important points of intervention after AMI.

Outlaw Motorcycle Gangs: Lessons for ED Personnel

Outlaw Motorcycle Gangs: Lessons for ED Personnel | Feature

Outlaw motorcycle gangs (OMGs) are an iconic element of the criminal landscape in the United States. “When an injured member of an OMG is brought to the ED, other members and associates are likely to come to the ED to support him,” say Anand N.…

Guidelines for Metastatic Castration-Resistant Prostate Cancer

Guidelines for Metastatic Castration-Resistant Prostate Cancer | Feature

According to current estimates, prostate cancer is the second leading cause of cancer deaths among North American men, with more than 33,000 dying from the disease in 2013. For men with androgen-sensitive metastatic disease, continuous androgen-deprivation therapy is considered the current standard of care, but many of these individuals will go on to develop castration-resistant prostate cancer (CRPC).…

[1]2345...102030...